جستجوی استاد راهنمای دانشگاهی

Dr. Yamin Zhang (张亚敏) holds a Presidential Young Professorship as an Assistant Professor in the Department of Chemical & Biomolecular Engineering at the National University of Singapore (NUS), College of Engineering. She leads the Zhang Group which focuses on interdisciplinary research at the intersection of electrochemistry, materials science, and biomedical engineering. 07/2023 – 01/2024: Research Associate, Northwestern University 02/2021 – 06/2023: Postdoctoral Fellow, Northwestern University 08/2016 – 12/2020: Ph.D., Chemical Engineering, Georgia Institute of Technology 09/2012 – 07/2016: B.S., Chemical Engineering, Tianjin University; B.S., Finance (Double Major), Nankai University Dr. Zhang's research centers on developing advanced electrochemical strategies for next-generation medical devices (implantable, bioresorbable, and wearable) and sustainable energy solutions. Her work bridges bioelectronics , battery technology , and medical therapeutics , with particular emphasis on creating devices that can safely dissolve in the body after serving their purpose. Key areas include bioresorbable optoelectronic systems for electrotherapy, self-powered drug delivery platforms, and eco-safe battery technologies that can harmlessly resorb in biological environments. Analysis of Dr. Zhang's publication record reveals a clear trajectory from fundamental battery chemistry (2021-2022) toward increasingly sophisticated medical applications (2023-2025). Her recent work demonstrates mastery in integrating multiple functionalities into single bioresorbable platforms, as evidenced by her Nature (2025) paper on millimeter-scale optoelectronic systems for electrotherapy and Cell Biomaterials (2025) paper on wireless bioelectronic devices. The research shows strong interdisciplinary collaboration with leading institutions including Northwestern University and Georgia Tech. AHA Early Faculty Independence Award (2023) MIT ChemE Rising Stars (2022) Sigma Xi Best PhD Thesis Award (2021) Chinese Government Award for Outstanding Students Abroad (2021) A*STAR MTC Young Individual Research Grants (YIRG) (2025) Early Career Board Member for ACS Applied Materials & Interfaces (2025) Dr. Zhang has secured significant research funding including the AHA's Second Century Early Faculty Independence Award as Principal Investigator (2023) and the A*STAR MTC Young Individual Research Grant (2025). Her group serves on advisory boards for Cell Biomaterials and ACS Applied Materials & Interfaces. The Zhang Group at NUS maintains active collaborations with Northwestern University researchers including the Rogers group, with whom she has co-authored multiple high-impact publications in Nature, Science, and PNAS. Current research focuses on advancing battery technology and developing sophisticated electrochemical strategies for medical devices with an overarching focus on healthcare innovation and environmental sustainability.

• Bioelectronics
• Bioresorbable Medical Devices
• Electrotherapy
• +۶ مورد دیگر

Karen C. Cheung is a Professor in the Department of Electrical and Computer Engineering at the University of British Columbia, with cross-appointments in the Faculty of Medicine and the School of Biomedical Engineering where she serves as Director of the Graduate Program. She holds her office in KAIS 3064 and can be reached at (604) 827-4114. Dr. Cheung received her BSc and PhD degrees in Bioengineering from the University of California, Berkeley in 1998 and 2002, respectively. From 2002-2005, she was a postdoctoral researcher at the École Polytechnique Fédérale de Lausanne in Switzerland. She joined UBC in 2006 and has established herself as a leading researcher in biomedical microsystems. Her research spans multiple areas of biomedical engineering with particular focus on lab-on-a-chip systems for cell culture and characterization , inkjet printing for tissue engineering , and implantable neural interfaces . Her work integrates microfluidics, biosensors, and tissue engineering to create platforms that better mimic in vivo conditions for drug screening and disease modeling. Current projects include developing organ-on-a-chip models of the human airway for studying aerosol exposure effects, creating microscale tumor models for cancer research, and advancing silicon photonic biosensors for medical diagnostics. Dr. Cheung leads the Bio-Medical Micro Devices Laboratory at UBC, which houses multiple research teams working on cutting-edge biomedical technologies. Her lab has developed microfluidic platforms capable of precisely controlling oxygen levels around tumor spheroids to study cancer treatment responses under realistic physiological conditions. The lab also works on novel fabrication techniques for microelectrode arrays and tissue clearing protocols for 3D imaging of microtissues. As an educator, Dr. Cheung teaches several specialized courses including ELEC 361 (Molecules to Mechanisms), ELEC 464 (Nanotechnology and Nature), EECE 301 (Topics in Nanotechnology and Microsystems), ELEC 473 (Biological Micro-Electro-Mechanical Systems), and ELEC 521 (Biomedical Microdevices). She has supervised numerous graduate students through their MASc, PhD, and postdoctoral work, with many alumni now holding academic positions or working in the biomedical industry. Her research is supported through multiple funding sources and collaborations with industry partners. Dr. Cheung is affiliated with several research centers including the Airway Centre, Bionics Network, Centre for Blood Research, and the Institute for Computing, Information and Cognitive Systems (ICICS) at UBC.

• Biomedical microsystems
• Lab-on-a-chip systems
• Tissue engineering
• +۹ مورد دیگر

Professor Matthias Mann is a world-leading scientist serving as Director of the Proteomics and Signal Transduction department at the Max Planck Institute of Biochemistry in Martinsried, Germany, and Director of the Proteomics department at the Novo Nordisk Foundation Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Denmark. With an h-index exceeding 277 and over 350,000 citations, he is recognized as the highest cited German researcher and one of the most influential scientists globally in proteomics. His educational background includes: Ph.D. in Chemical Engineering from Yale University (1988) Master's Degree in Physics from Georg August University Göttingen (1984) Bachelor's of Arts in Mathematics from Georg August University Göttingen (1982) Professor Mann's research focuses on advancing mass spectrometry-based proteomics to understand biological systems at the protein level. His work spans technological developments in mass spectrometry, bioinformatics and computational analysis, signal transduction and posttranslational modifications, and clinical proteomics applications for disease diagnosis and treatment. The Mann lab has pioneered groundbreaking methods like SILAC for quantitative proteomics and MaxQuant for proteome data analysis. Their vision is to translate proteomics knowledge into clinical practice for predictive, diagnostic, and preventive medicine, with recent work focusing on AI-guided platforms for analyzing proteomes from minimal tissue samples. Analysis of Professor Mann's recent publications reveals a strong trend toward clinical applications of proteomics, particularly in cancer research, metabolic diseases, and neurodegenerative disorders. His work increasingly integrates spatial proteomics, single-cell resolution techniques, and artificial intelligence approaches to uncover disease mechanisms and identify potential biomarkers, with a clear shift from basic technology development toward direct clinical applications and personalized medicine. Professor Mann has received numerous prestigious awards throughout his career: 2025: Elected member of the American National Academy of Sciences 2024: Dr. H.P. Heineken Award for Biochemistry and Biophysics 2023: Otto Warburg Medal 2019: Nominated member of the Bavarian Academy of Sciences 2013: Elected member of Leopoldina German National Academy of Sciences 2012: Körber European Science Award, Louis-Jeantet Foundation Prize for Medicine, Ernst Schering Prize, and Leibniz Prize Professor Mann leads a highly collaborative research team involved in multiple international networks including the Bill & Melinda Gates Foundation, Michael J. Fox Foundation for Parkinson's Research, CLINSPECT-M, and Munich Heart Alliance. His lab has mentored numerous successful researchers, with several former postdocs receiving prestigious ERC Starting Grants. The Mann group has developed innovative clinical proteomics pipelines for analyzing archived tissue specimens and body fluids, aiming to identify protein markers for early detection of diseases such as diabetes and cancer. The Mann lab operates across two major research centers with state-of-the-art mass spectrometry facilities. Their Clinical Knowledge Graph platform integrates multi-omics data with extensive metadata, creating an ecosystem for machine learning applications in proteomics. Current research focuses on developing highly sensitive methods that can profile thousands of proteins from minimal cell samples, enabling the identification of critical disease-related proteins and supporting the development of individualized therapies.

• Mass Spectrometry
• Proteomics
• Systems Biology
• +۶ مورد دیگر

JIANG Xingyu is Chair Professor and Head of the Department of Biomedical Engineering at the Southern University of Science and Technology (SUSTech) . Since 2018 he has led a multidisciplinary team developing advanced micro- and nano-scale tools for analytical chemistry, microfluidics and nanomedicine. Education Postdoctoral Research, Harvard University (2004–2005) Ph.D. in Chemistry, Harvard University (2004) B.S. in Chemistry, University of Chicago (1999) Research Interests Professor Jiang’s research integrates analytical chemistry , microfluidics , biomedical engineering and nanomedicine . His laboratory designs microfluidic chips for point-of-care diagnostics, engineers gold nanoclusters and nanoparticles for antimicrobial and anticancer therapy, and develops soft flexible bio-electronics for neural interfaces and wearable health monitoring. Across 400+ publications, recent work demonstrates a clear trend toward translational nanomedicine : point-of-care viral variant detection, nanoantibiotic strategies against multidrug-resistant bacteria, CRISPR delivery systems for cancer therapy, and conformal electronic tattoos for human-machine interfaces. Scientific Awards & Honours Fellow, American Institute for Medical and Biological Engineering (2020) Fellow, Royal Society of Chemistry (2016) Tencent Science Exploration Award (2019) Chief Scientist, National Key R&D Program (2019–) National Science Fund for Distinguished Young Scholars (2010) Young Investigator Award, Human Frontier Science Program (2007) Research Funding & Teams He currently directs the Nanoscience Laboratory at SUSTech, hosts National Key R&D Program projects as Chief Scientist, and serves on editorial boards of Advanced Healthcare Materials , Lab on a Chip , Nanoscale Horizons , Nanoscale and Nanoscale Advances . The group is actively recruiting post-docs, research professors and technicians across chemistry, materials, biology and medical engineering disciplines.

• Analytical Chemistry
• Microfluidics
• Biomedical Engineering
• +۲ مورد دیگر

Daniel Redwood serves as Director of the MS in Nutrition & Functional Medicine at the University of Western States (UWS), a leading institution in integrated health care. With 25 years of clinical chiropractic experience emphasizing nutrition and acupuncture, he previously held a professorship at Cleveland Chiropractic College - Kansas City where he supervised student interns and taught clinical nutrition. His educational background includes: BA in English, State University of New York at Buffalo Doctor of Chiropractic, Palmer College of Chiropractic Dr. Redwood's research focuses on the integration of nutrition and functional medicine within chiropractic practice, advocating for evidence-based holistic models that prioritize prevention and self-care. His work bridges conventional and complementary medicine through clinical applications in pain management, chronic disease prevention, and lifestyle interventions. His scholarly output demonstrates a clear evolution from foundational chiropractic principles toward integrative approaches, with increasing emphasis on evidence-based nutrition protocols and interdisciplinary collaboration in health care delivery systems. Key recognitions include: Educator of the Year (Missouri State Chiropractic Association) Six-time Virginia Chiropractic Association Literary Award winner As an educator and academic leader, he has shaped curriculum development through editorial roles including founding editor of The Journal of Alternative and Complementary Medicine and current associate editor of Topics in Integrative Healthcare. His consulting work with WebMD and Integrative Medicine Consult extends his influence into digital health platforms. Dr. Redwood actively builds bridges between medical disciplines through his leadership at UWS and participation in the Research Agenda Conference (RAC), positioning functional medicine as central to the future of integrated health care systems.

• Nutrition
• Functional Medicine
• Chiropractic
• +۳ مورد دیگر

Robert O. Ritchie is the H. T. & Jessie Chua Distinguished Professor of Engineering at the University of California, Berkeley, where he holds dual appointments as Professor of Materials Science & Engineering and Professor of Mechanical Engineering. He is also a Faculty Senior Scientist at Lawrence Berkeley National Laboratory. His distinguished career spans over four decades with significant contributions to the field of materials science and engineering. Professor Ritchie received his B.A. in Physics & Metallurgy (1969), M.A. in Materials Science (1973), Ph.D. in Materials Science (1973), and Sc.D. in Materials Science (1990), all from Cambridge University, UK. His research focuses on the mechanical behavior of advanced materials, with particular emphasis on fracture mechanics, fatigue properties, and damage tolerance. Professor Ritchie's work spans multiple domains including metallic glasses, high-entropy alloys, biomaterials, and nature-inspired structural materials. His laboratory employs cutting-edge techniques such as in situ high-temperature computed tomography to study failure mechanisms in ceramic-matrix composites and nuclear graphite. His research has significant implications for aerospace, biomedical, and energy applications. Analysis of Professor Ritchie's recent publications reveals a strong focus on advanced structural materials, particularly metallic glasses and high-entropy alloys. His work combines experimental approaches with computational modeling to understand deformation mechanisms at multiple length scales. There is a clear trend toward bioinspired materials design, with several papers examining natural structures like fish scales, horn sheaths, and bone to develop new engineering materials with exceptional mechanical properties. Member, National Academy of Sciences (2025) Foreign Fellow, Academy of Athens, Greece (2024) Robert Henry Thurston Award (ASME) (2022) ASM Gold Medal (ASM Intl.) (2021) William D. Nix Medal, inaugural winner (TMS) (2020) Fellow (Foreign Member) of the Royal Society (FRS), London, UK (2017) Morris Cohen Award (TMS) (2017) Acta Materialia Gold Medal (2014) David Turnbull Award (MRS) (2013) A. Cemel Eringen Medal (Society of Engineering Science) (2010) Professor Ritchie has advised numerous graduate students and postdoctoral researchers throughout his career. His research has been supported by various funding agencies including the Department of Energy, National Science Foundation, and industry partners such as Rolls-Royce. He has served on numerous advisory boards including the Rolls-Royce Materials & Structures Advisory Board (2011-2019) and the Scientific Advisory Board of the Advanced Light Source at LBNL (2013 to date). Professor Ritchie leads the Ritchie Group at UC Berkeley, which maintains strong collaborations with Lawrence Berkeley National Laboratory. The laboratory employs state-of-the-art techniques including electron microscopy, x-ray tomography, and mechanical testing across multiple length and time scales. His team has developed innovative in situ characterization methods that have significantly advanced the understanding of material failure mechanisms under extreme conditions.

• Materials Science
• Mechanical Engineering
• Fracture Mechanics
• +۷ مورد دیگر

Juliane Nguyen, PhD, is a Professor in the Department of Pharmacoengineering and Molecular Pharmaceutics at the UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill. She serves as Vice Chair and Director of Graduate Admissions in her department and holds an adjunct appointment as Professor of Biomedical Engineering. Dr. Nguyen is also a member of the UNC Lineberger Comprehensive Cancer Center, where she applies molecular engineering approaches to develop innovative therapeutic solutions. Dr. Nguyen's research focuses on molecular engineering to advance protein-based therapeutics, live biotherapeutics (including engineered probiotic yeast), and extracellular vesicles. Her lab develops cutting-edge technologies to treat diverse conditions including cancer, myocardial infarction, chemotherapy-induced cardiotoxicity, and inflammatory bowel diseases. Her interdisciplinary approach integrates molecular engineering, pharmaceutical sciences, and bioinformatics to create complex biologics with exceptional safety and efficacy profiles. Key research areas include developing therapeutics for cardiac repair, genetically encoded materials targeting tumor-associated macrophages, live biotherapeutics for inflammatory bowel diseases using engineered probiotic yeast, and auxetic patches for dynamic organ repair. Analysis of Dr. Nguyen's recent publications reveals a strong focus on translational research with significant contributions to cardiac repair technologies, cancer immunotherapy, inflammatory bowel disease treatments, and advanced biomaterials. Her work consistently bridges fundamental molecular engineering with clinical applications, particularly in the areas of targeted drug delivery, extracellular vesicle therapeutics, and engineered live biotherapeutics. The research demonstrates a clear trajectory toward developing clinically viable solutions for previously challenging medical conditions. Dr. Nguyen has received numerous prestigious awards and honors including the NSF CAREER Award (2018), Eshelman Innovation Award (2020), and recognition as a Fellow of the Controlled Release Society (2023). She was appointed as a Standing Member of the NIH Drug and Biologic Therapeutic Delivery Study Section (2023-2025) and serves as Executive Editor of Advanced Drug Delivery Reviews since 2021. Her Galenus Guest Professorship at ETH Zuerich (2024) and keynotes at major conferences highlight her international recognition in the field. As Director of Graduate Admissions and an active mentor, Dr. Nguyen has advised numerous PhD and Master's students who have co-authored significant publications with her. Her research is supported by competitive grants including the NSF CAREER Award and other NIH-funded projects. The Nguyen Lab maintains strong collaborations across disciplines, particularly with cardiology, oncology, and biomedical engineering researchers. She leads an interdisciplinary team focused on translating molecular engineering breakthroughs into clinically impactful therapies. The Nguyen Lab operates as a dynamic, interdisciplinary research environment combining expertise in molecular engineering, pharmaceutical sciences, and bioinformatics. The lab's mission is to revolutionize medicine by developing next-generation therapeutics that target diseases at the molecular level. Current projects focus on translating cutting-edge research into life-changing therapies for patients suffering from cancer, myocardial infarction, colitis, and other challenging conditions. The lab's innovative approach to biomolecular engineering positions it at the forefront of developing safe, effective, and personalized therapeutic solutions.

• Molecular Engineering
• Protein-based Therapeutics
• Live Biotherapeutics
• +۷ مورد دیگر

Dr. Christina Leslie is a Research Professor and Member of the Computational & Systems Biology Program at Memorial Sloan Kettering Cancer Center (MSK). She leads an active research laboratory focused on developing computational approaches to understand complex biological systems. Dr. Leslie earned her PhD from the University of California, Berkeley and has established herself as a leading computational biologist in cancer research and immunology. Computational & Systems Biology Program, Memorial Sloan Kettering Cancer Center Gerstner Sloan Kettering Graduate School of Biomedical Sciences Dr. Leslie's research focuses on developing novel computational methods to study cellular biological systems from a global and data-driven perspective. Her lab exploits diverse high-throughput functional and genomic data to understand molecular networks underlying fundamental cellular processes, including transcription regulation, pre-mRNA processing, signaling, and post-transcriptional gene silencing. Her algorithmic methods draw heavily on machine learning to build accurate predictive models from noisy and high-dimensional biological data. Key areas of interest include modeling cell-type specific transcriptional programs and dissecting co- and post-transcriptional regulation, particularly microRNA-mediated gene regulation. Analysis of Dr. Leslie's publication record over the last five years reveals a strong focus on computational approaches to cancer genomics, immunology, and epigenetics. Her work bridges multiple disciplines, with a particular emphasis on developing machine learning methods to interpret complex biological data. The publications demonstrate increasing sophistication in integrating multiple data types (genomic, transcriptomic, epigenomic) to understand cancer biology and immune responses. Recent work shows a growing emphasis on single-cell technologies and spatial analysis of tumor microenvironments. Introduction of string kernel methodology for SVM classification of biological sequences Development of algorithms for predictive modeling of gene regulation First systems-level analyses of competition between microRNAs and between target transcripts Dr. Leslie actively mentors numerous graduate students and research associates, with current lab members including Vianne Gao, Alireza Karbalaghareh, Erik Ladewig, and several others. Her lab has received significant research funding to support their work on computational approaches to cancer biology and immunology. The Leslie Lab maintains close collaborations with multiple experimental groups at MSK, facilitating the translation of computational insights into biological understanding. The Leslie Lab operates within the Computational & Systems Biology Program at MSK, with strong ties to both the research and clinical missions of the institution. The lab maintains state-of-the-art computational infrastructure for analyzing large-scale genomic and proteomic datasets and collaborates extensively with wet-lab researchers to validate computational predictions experimentally.

• Computational Biology
• Systems Biology
• Machine Learning
• +۷ مورد دیگر

Tobias Sjöblom serves as Professor and Head of Department at Uppsala University's Department of Immunology, Genetics and Pathology, where he leads the Cancer Precision Medicine research program. His work bridges clinical oncology and molecular biology, with particular focus on translating genomic findings into clinical applications for cancer patients. His research interests center on cancer genomics, precision medicine, and molecular diagnostics, with extensive work on colorectal cancer biology and treatment. Sjöblom's laboratory investigates how genetic variations influence cancer development, progression, and response to therapy, particularly focusing on pharmacogenomic biomarkers that can guide personalized treatment decisions. His work spans from basic molecular mechanisms to clinical applications, with strong emphasis on translating research findings into clinical practice. Analyzing his recent publication record reveals a clear trajectory toward precision oncology applications, with increasing focus on liquid biopsy technologies, AI-assisted diagnostics, and biomarker-driven treatment strategies. His research demonstrates a consistent pattern of investigating how specific genetic alterations (particularly in NAT2, CYP2D6, and other metabolic enzymes) can be leveraged for targeted cancer therapies. The interdisciplinary nature of his work is evident in collaborations spanning molecular biology, clinical oncology, bioinformatics, and medical imaging. Sjöblom has established significant research infrastructure through initiatives like the U-CAN biobank, creating valuable resources for cancer research across Sweden. His leadership extends to developing novel methodologies for cancer genomics and diagnostics, including advanced techniques for mutation detection and tissue analysis. His laboratory maintains strong clinical connections, working closely with oncologists and surgeons to ensure research questions address real clinical challenges. This translational approach has resulted in numerous publications in high-impact journals including Nature, Science, and Cell Death and Disease, demonstrating the significance and quality of his contributions to cancer research.

• Cancer Genomics
• Precision Medicine
• Colorectal Cancer Research
• +۵ مورد دیگر

Prof. Dr. Soeren Lienkamp is an Assistant Professor at the Institute of Anatomy , Faculty of Medicine , University of Zurich . His work bridges digital education and genetic research , focusing on enhancing medical teaching through innovative formats. Research Interests : Genetics, developmental biology, kidney disease modeling, CRISPR applications, digital medical education, and advanced microscopy. Methodologies : Combines Xenopus tropicalis models, deep learning , and bioengineering to study genetic kidney disorders and improve diagnostic tools. Publication Trends : His recent articles highlight predictable genome editing , 3D imaging technologies , and mechanistic insights into kidney and eye development. Earlier works focus on ciliary function , Wnt signaling , and metabolic stress in renal cells.

• Molecular Biology
• Genetics
• Developmental Biology
• +۵ مورد دیگر

Dr. Su Ryon Shin is an Assistant Professor in the Division of Engineering in Medicine at Harvard Medical School and Brigham and Women's Hospital (BWH) in Cambridge, MA. She leads an active research laboratory focused on bioengineering, tissue engineering, and regenerative medicine, with particular expertise in 3D bioprinting, biomaterials, and organ-on-a-chip technology. Her research interests span biohybrid robotics, decellularized extracellular matrix, stem cell-based tissue engineering, and volumetric muscle regeneration . Dr. Shin's work integrates advanced biomaterials with cellular systems to create innovative solutions for tissue regeneration and disease modeling. She has pioneered approaches using human stem cell-derived materials for volumetric tissue regeneration and developed biohybrid neuromuscular robots powered by living cardiac muscle cells. Her publication record demonstrates consistent productivity with over 180 publications, including numerous first/senior author papers in high-impact journals like Science Robotics, Advanced Materials, and Nature Reviews Bioengineering . Her work shows a clear progression from fundamental biomaterials development to increasingly complex tissue engineering applications and translational research. Dr. Shin has received significant recognition including being named a 2025 BWH Health & Technology Innovation Awardee , Highly Cited Researcher 2024 by Web of Science, and multiple Stepping Strong Innovator Awards (2015, 2018, 2020). Her research has been featured in Nature Reviews Bioengineering for breakthrough work on biohybrid robots. She actively mentors students and postdocs, with former lab members accepted to prestigious programs like MIT's PhD program in Chemical Engineering. Her collaborative approach is evident through numerous interdisciplinary projects with researchers across Harvard Medical School, BWH, and international institutions.

• Bioengineering
• Tissue Engineering
• 3D Bioprinting
• +۷ مورد دیگر

Ueli Grossniklaus is an Ordinary Professor at the University of Zurich within the Faculty of Mathematical and Natural Sciences , affiliated with the Department of Plant and Microbiology . His work focuses on plant developmental biology, particularly epigenetic and genetic mechanisms governing reproduction and adaptation. Key Courses: Epigenetics, Plant Biology Workshop, Group Seminars on Current Research Laboratory Techniques: Advanced methods in plant cell mechanics, transcriptomics, and genome editing Research Interests span plant epigenetics, reproductive biology, and the interplay between environmental stress and genetic regulation. He investigates: Mechanistic control of gametogenesis and fertilization Epigenetic contributions to plant adaptation Evolutionary implications of asexual reproduction Biophysical forces in plant cell growth Publication Trends (2025–2018) reveal expertise in: Arabidopsis and fern model systems Epigenetic regulation (DNA methylation, histone dynamics) Apomixis and hybrid seed failure mechanisms Biomechanics of pollen tubes and carnivorous plants Genome editing tools (CRISPR) and long-read sequencing Scientific Collaborations include interdisciplinary projects on: Microfluidic devices for plant cell analysis Gene drive ecology and ethics 3D imaging of plant reproductive structures Advising and Grants focus on mentoring through research internships in developmental biology, genetics, and systems biology. His lab engages in: Epigenetic response to environmental stress Cell wall mechanics in reproduction Computational modeling of plant growth Laboratory Teams integrate plant biologists, bioengineers, and computational scientists to study: Mechanistic gene regulation Evolutionary developmental biology Microrobotics for cellular force measurement

• Plant Developmental Biology
• Epigenetics
• Plant Genetics
• +۵ مورد دیگر

Michael N. Economo, PhD, is an Assistant Professor in the Department of Biomedical Engineering at Boston University. His research focuses on neural circuits controlling movement, leveraging cutting-edge optical, electrophysiological, and genetic tools. He holds affiliations with Neuroscience & Neuroengineering and Photonics & Optical Systems programs. Education: PhD in Biomedical Engineering from Boston University, B.S. Biomedical Engineering and B.A. Mathematics from Duke University. Research Interests: Systems neuroscience, motor control, long-range neural circuits, computational neuroscience, neurotechnology. His lab investigates how neural circuits across brain regions coordinate movement using advanced techniques like optogenetics, in vivo imaging, and transcriptomics. Key Projects: Orofacial motor control, voltage imaging with TICO microscopy, neural circuit dissection. Technologies: Neuropixels probes, fluorescent voltage indicators, single-cell RNA sequencing. Notable Awards: NSF CAREER (2023), Scialog Fellow (2023), Whitehall Foundation Young Investigator Award (2021). Advising & Grants: Supervises graduate students (e.g., Munib Hasnain, Jackie Birnbaum) and postdocs (e.g., Vicky Moya, Yujin Han). Lab members focus on motor planning, neuromodulation, and neural dynamics. Labs/Teams: The Economo Lab collaborates on neurotechnology development and integrates interdisciplinary approaches from engineering and biology. Affiliated with BU’s Graduate Program in Neuroscience.

• Systems Neuroscience
• Motor Control
• Neural Circuits
• +۳ مورد دیگر

Shaji K Chacko, Ph.D., is an Instructor in the Department of Pediatrics – Nutrition at Baylor College of Medicine, where he leads an independent research laboratory at the USDA/ARS Children's Nutrition Research Center in Houston, Texas. His work focuses on metabolic regulation, particularly glucose production pathways in health and disease. BS, Nagpur University (1990) MS, Barkatullah University (1992) MS, University of Houston, Clear Lake (2000) PhD, University of Groningen (2011) Dr. Chacko's research centers on glucose metabolism , specifically gluconeogenesis and glycogenolysis , using stable isotope tracers and mass spectrometry. His lab investigates metabolic dysfunctions in conditions such as insulin resistance, type 2 diabetes, and post-surgical states, with a strong focus on pediatric and neonatal populations. He also studies total energy expenditure using the doubly labeled water method in free-living subjects. The 15 most recent publications reflect a consistent focus on metabolic regulation, particularly in insulin resistance , obesity , diabetes , and parenteral nutrition . Key themes include hormonal regulation (e.g., leptin), amino acid metabolism (glycine, BCAA), liver function, and therapeutic interventions like metformin and nutritional supplements. His work frequently involves translational models, including human clinical studies and genetically modified animal models. Dr. Chacko has not received any explicitly mentioned scientific awards in the provided texts. He mentors lab members such as Zhensheng Chen (Research Associate) and collaborates extensively with clinicians and scientists, including M.W. Haymond and F. Jahoor. While no specific grants are listed, his research likely involves externally funded projects given the scope and equipment required for stable isotope and mass spectrometry studies. His lab benefits from the state-of-the-art facilities at the Children's Nutrition Research Center, including a metabolic kitchen, greenhouse, and advanced instrumentation. The Shaji Chacko Lab is embedded within the USDA/ARS Children's Nutrition Research Center, a multidisciplinary hub housing elite scientists conducting cutting-edge research in pediatric nutrition and metabolism. The center provides extensive resources including specialized laboratories, research accommodations, and a collaborative scientific environment.

• Glucose Metabolism
• Gluconeogenesis
• Glycogenolysis
• +۱۲ مورد دیگر

Zelmina Lubovac is a Senior Lecturer in BioInformatics at the School of Bioscience, University of Skövde. She serves as both a Course Coordinator for multiple undergraduate and graduate courses in bioinformatics and a Programme Coordinator for Master's level programs. Her academic work focuses on the intersection of computational methods and biological applications, particularly in disease analysis and biomarker discovery. Dr. Lubovac's research spans several key areas in bioinformatics and systems biology: Disease module identification in complex biological networks Multi-omics integration (genomics, proteomics, metabolomics) for biomarker discovery Machine learning applications in RNA-seq and other high-throughput biological data Development of bioinformatics software tools for network analysis miRNA analysis in cancer and neurological disorders Her recent publications (2022-2024) demonstrate a strong focus on applying computational approaches to understand disease mechanisms, particularly in pancreatic cancer and multiple sclerosis. She has developed several widely-used bioinformatics tools including MODalyseR, MODifieR, and TFTenricher that facilitate disease module analysis and gene network interpretation. Her work often involves collaborative research with clinical teams to translate computational findings into potential diagnostic applications. Dr. Lubovac has been involved in significant research projects including: BIO-AID (Biomedical AI-driven data analytics): Oct 2020 - Sep 2024 Systems Biology DMDPipe: Mar 2018 - Feb 2021 She actively contributes to both undergraduate and graduate education at the University of Skövde, coordinating multiple courses and programs in bioinformatics and bioscience, with a clear emphasis on preparing students for careers at the intersection of biology and computational science.

• Bioinformatics
• Systems Biology
• Disease Module Identification
• +۶ مورد دیگر